期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
清胰汤通过lncRNA-PVT1竞争性结合miR-146a靶向TRAF6参与重症胰腺炎发生发展的机制研究 被引量:2
1
作者 赖纪英 卢涵婧 +3 位作者 郭宗文 岳霖琳 刘欣 刘晓峰 《中国医药指南》 2023年第32期28-31,共4页
目的探讨清胰汤通过lncRNA-PVT1竞争性结合miR-146a靶向肿瘤坏死因子受体相关因子6(TRAF6)参与重症胰腺炎发生发展的机制。方法购置SD大鼠50只,随机取10只设为空白对照组;剩余40只大鼠经肠壁穿刺逆行胰胆管注射5%牛磺胆酸钠注射制备重... 目的探讨清胰汤通过lncRNA-PVT1竞争性结合miR-146a靶向肿瘤坏死因子受体相关因子6(TRAF6)参与重症胰腺炎发生发展的机制。方法购置SD大鼠50只,随机取10只设为空白对照组;剩余40只大鼠经肠壁穿刺逆行胰胆管注射5%牛磺胆酸钠注射制备重症胰腺炎动物模型,建模成功后随机取10只为模型对照组;剩余30只大鼠利用慢病毒转染干扰lncRNA-PVT1序列(LV-shPVT1)及空载(LV-control),分为清胰汤组、清胰汤+空载组和清胰汤+PVT1沉默组,每日用药1次,比较各组HE染色、炎症因子及TRAF6及细胞凋亡相关基因表达。结果HE染色结果表明,清胰汤组病理学改善显著,胰腺组织内炎症细胞浸润减轻明显;清胰汤+空载组和模型组可见微血栓形成,且随着时间延长加重,炎症细胞浸润明显,伴有上皮细胞浸润。清胰汤组TNF-α、IL-1β、TRAF6表达水平均低于清胰汤+空载组和清胰汤+PVT1沉默组(均P<0.05);清胰汤组miR-146a表达水平高于清胰汤+空载组和清胰汤+PVT1沉默组(P<0.05);清胰汤组细胞凋亡相关基因β-actin、ki-67、Bax、caspase、Caspase-9表达水平低于清胰汤+空载组和清胰汤+PVT1沉默组(均P<0.05)。结论在重症胰腺炎中,清胰汤能通显著下调lncRNA-PVT1表达,促进miR-146a表达,抑制TRAF6的表达,作用于炎症信号通路,降低炎症因子水平,抑制细胞凋亡,抑制重症胰腺炎的病理进展。 展开更多
关键词 重症胰腺炎 清胰汤 lncrnapvt1 MIR-146A 肿瘤坏死因子受体相关因子6
暂未订购
Long non-coding RNA PVT1 mediates bile acid-induced gastric intestinal metaplasia via a miR-34b-5p/HNF4α positive feedback loop
2
作者 Kexin Lin Nuo Yao +7 位作者 Xingyu Zhao Xiaodong Qu Xuezhi Li Songbo Li Shiyue Luo Min Chen Na Wang Yongquan Shi 《Chinese Medical Journal》 2025年第18期2324-2335,共12页
Background:Bile acids(BAs)facilitate the progression of gastric intestinal metaplasia(GIM).Long non-coding RNAs(lncRNAs)dysregulation was observed along with the initiation of gastric cancer.However,how lncRNAs functi... Background:Bile acids(BAs)facilitate the progression of gastric intestinal metaplasia(GIM).Long non-coding RNAs(lncRNAs)dysregulation was observed along with the initiation of gastric cancer.However,how lncRNAs function in GIM remains unclear.This study aimed to explore the role and mechanism of lncRNA PVT1 in GIM,and provide a potential therapeutic target for GIM treatment.Methods:We employed RNA sequencing(RNA-seq)to screen dysregulated lncRNAs in gastric epithelial cells after BA treatment.Bioinformatics analysis was conducted to reveal the regulatory mechanism.PVT1 expression was detected in 21 paired biopsies obtained under endoscopy.Overexpressed and knockdown cell models were established to explore gene functions in GIM.Molecular interactions were validated by dual-luciferase reporter assay,RNA immunoprecipitation(RIP),and chromatin immunoprecipitation(Ch-IP).The levels of relative molecular expression were detected in GIM tissues.Results:We confirmed that lncRNA PVT1 was upregulated in BA-induced GIM model.PVT1 promoted the expression of intestinal markers such as CDX2,KLF4,and HNF4α.Bioinformatics analysis revealed that miR-34b-5p was a putative target of PVT1.miR-34b-5p mimics increased CDX2,KLF4,and HNF4αlevels.Restoration of miR-34b-5p decreased the pro-metaplastic effect of PVT1.The interactions between PVT1,miR-34b-5p,and the downstream target HNF4α were validated.Moreover,HNF4αcould transcriptionally activated PVT1,sustaining the GIM phenotype.Finally,the activation of the PVT1/miR-34b-5p/HNF4α loop was detected in GIM tissues.Conclusions:BAs facilitate GIM partially via a PVT1/miR-34b-5p/HNF4α positive feedback loop.PVT1 may become a novel target for blocking the continuous development of GIM and preventing the initiation of gastric cancer in patients with bile reflux. 展开更多
关键词 lncrnapvt1 miR-34b-5p HNF4α Gastric intestinal metaplasia Bile acids Long non-coding RNAs
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部